Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Director

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest / Changes in Interest of Substantial Shareholder

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest of Director / Chief Executive Officer

Register of shareholders, changes and capital status – exercise of non-tradable warrants

Q1 2026 report - iXBRL report

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Gildan Activewear Inc.

FinVolution Group Publishes Eighth Annual ESG Report

Yiren Digital to Report First Quarter 2026 Financial Results on June 25, 2026

Register of shareholders, changes and share capital status – issuance of shares as a result of exercising employee warrants

Forrester Opens Nominations For Its 2026 B2B Awards In EMEA